Summary
Updated Aug 31, 2026
Peter T. Slover is Chief Financial Officer of Contineum Therapeutics, Inc. (CTNM). 1 SEC Form 4 filing on record, dated 30 January 2026.
Trading Pattern
InsiderAlpha's records for Peter T. Slover go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Peter T. Slover files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel S. Lorrain - $1.04M of CTNM open-market activity in the last 12 months
- Carmine N. Stengone - $360K of CTNM open-market activity in the last 12 months
- Tim Watkins - $279K of CTNM open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Peter T. Slover?
Peter T. Slover is a corporate insider, tracked as Chief Financial Officer of Contineum Therapeutics, Inc. (CTNM). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Peter T. Slover last file a Form 4?
The only primary Form 4 on record is dated 30 January 2026.
Where can I see all of Peter T. Slover's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Peter T. Slover and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial